New Report: Non-Pharmacological Interventions for Alzheimer’s Show Promise

UsA2 Urges Medical System Engagement with Science Around Prevention and Early Detection, Lifestyle Changes, and Comorbidity Management to Reduce Risk and Rate of Cognitive Decline

This World Alzheimer’s Month, Let's Talk About Dementia

Lynda Everman, Alzheimer's Semipostal Advocate and founder of WomenAgainstAlzheimer’s and ClergyAgainstAlzheimer’s, teaches us to multiply our voices and grow the Alzheimer's movement.

Register for the 2019 National Alzheimer's Summit TODAY!

Join UsAgainstAlzheimer’s and a dynamic group of multi-sector partners as we set goals and share strategies for developing a culture of brain health in homes, communities, and health systems.

BIOSPACE: “A Devil of a Disease”: The Current Alzheimer’s Pipeline

Chairman and co-founder of UsAgainstAlzheimer’s, George Vradenburg, on the current approaches to battling this disease.

LUNDBECK: Welcome to the New Era of Alzheimer’s Research

AD PACE founding sponsor, Lundbeck, explores how people with Alzheimer’s and care partners are shaping the future of drug development.

Brain Health Redux

UsA2 chairman and co-founder, George Vradenburg, reflects on the organization’s recent work and renews a call for a brain health check-up as a basic part of routine care.

Non-Pharma Report

World Alzheimer’s Month

2019 National Alzheimer's Summit

The Current Alzheimer’s Pipeline

New Era of Alzheimer’s Research

Brain Health Redux

  • A Letter from Our Chairman

    UsAgainstAlzheimer’s Brain Health Partnership has issued a Call to Action white paper outlining recommendations for building a better system of care to promote brain health and fight back against Alzheimer’s.

Read the Letter

We Are Committed to Stopping Alzheimer's by 2025.

  • Blog Post
    Thumbnail

    Forming Your “Circle of Help”

    The best way to defeat Alzheimer’s is to come together and gang up on the disease.
    Read more
  • Blog Post
    Thumbnail

    Growing Our Voices: Let’s Talk About Dementia

    1994: President Ronald Reagan penned his now famous letter to the American public announcing that he was in the early stages of Alzheimer’s disease. The same year, my dad

    Read more
  • Blog Post
    Thumbnail

    “A Devil of a Disease”: The Current Alzheimer’s Pipeline

    This article was originally published by BioSpace on August 7, 2019.

    By Mark Terry

    As anyone following Alzheimer’s research knows, drug development for the disease has been a wasteland of failed

    Read more

The Pulse of the Community: Volume 3, Spring 2019

The A-LIST transforms the stories of more than 8,000 people living with Alzheimer’s or other dementias into evidence-based insights by providing unique, rapid-response, self-reported data through virtual surveys on what matters most on a wide range of Alzheimer’s-related topics. The A-LIST offers a powerful and validating voice for those living with Alzheimer’s and those caring for them, and a pathway to help expand treatments and accelerate toward a cure.